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Summary  
A commercial preparation of 800-kDa hyaluronic acid (HA), (ARTZ from Seikagaku, Inc.), has been used as a 
therapeutic intervention i the treatment ofosteoarthritis (OA). We tested the effect of this HA form, HA/800, in an 
in vitro cartilage chondrolytic system in which a specific amino-terminal 29-kDa fragment of fibronectin (Fn-f) 
penetrates cartilage tissue to activate chondrocytes to amplify two major chondrolytic activities: suppression of 
proteoglycan (PG) synthesis and induction of matrix metalloproteinases. We report hat HA/800 did not block damage 
by Fn-f in serum free cartilage cultures. However, HA/800 was effective in blocking the ability of 100 aM Fn-f to cause 
the degradation and release of half of the total cartilage PG from cartilage in 10% serum/DMEM cultures. While the 
Fn-f caused a half-time for PG release of 3 days, continuous exposure to 0.1 or 1 mg/ml HA/800 slowed the half-time 
to 12 days. Further, a single 1 day pre-incubation with 0.1 or 1 mg/ml HA/800 was sufficient to decrease the half-time 
of 100 nM Fn-f mediated PG depletion to 7 and 12 days, respectively. HA/800 completely blocked the effect of 10 nM 
Fn-f. Blocking of Fn-f-mediated cartilage PG depletion was associated with a decreased concentration f Fn-f on the 
superficial cartilage surface and decreased penetration i to the cultured cartilage tissue. Further, the two major 
chondrolytic activities of the Fn-f, suppression of synthesis of PG and enhanced release of stromelysin-1, were 
suppressed by HA/800. HA/800 also partially restored PG in cartilage first damaged with the Fn-f. We conclude that 
HA/800 slows Fn-f-mediated cartilage chondrolysis n vitro and has some reparative potential. The damage blocking 
activity appears to be associated with the ability of HA/800 to block penetration of the Fn-f, rather than with direct 
effects on cartilage tissue. 
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Introduction 
,HYALURONIC ACID (HA) is a major component of 
~ov ia t  fluid, and plays a central role in 
~ rication within the knee joint cavity. HA 
lmrations have been used as a therapeutic 
mterv ~:'" ention in the treatment of osteoarthritis 
~()A) [1]. For example, several studies have shown 
~t  intra-articular HA treatment of osteoarthritic 
knees reduces painful symptoms and improves 
Iomt moblhty [2-4]. HA has also been used to treat 
traumatic arthritis and OA in horses [5-8]. 
Double-blinded studies that have compared HA 
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with placebo in intra-articular injection in 
patients with OA [9-11] and compared HA with 
intra-articular injection of steroids [12, 13] have 
also shown some subjective benefit. Some of these 
studies have suggested that the effects of HA may 
be directed toward synovial tissue [14]. The 
subjective benefit of HA, regarding pain reduction, 
may be related to analgesic properties as suggested 
in an experimental nimal model in which HA was 
shown to have an analgesic action on bradykinin- 
induced pain in the knee joints of rats [15] with 
high molecular weight HA producing long-lasting 
and significant analgesis [16]. The exact mechan- 
ism of this apparent pain relieving action is 
uncertain. 
The effects of HA have also been studied in cell 
culture and cartilage explant models of chondro- 
cytic chondrolysis. HA has been shown to have 
anti-inflammatory effects, including inhibition of 
phagocytosis [17, 18], inhibition of chemotaxis of 
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inflammatory cells [19], removal of free radicals 
and other reactive oxygen species [20] and 
inhibition of prostaglandin synthesis [21]. HA has 
also been shown to block proteoglycan (PG) 
release induced by interleukin-1 (IL-1) in rabbit 
articular chondrocytes in vitro [22], to inhibit IL-1 
induced PG degradation in bovine articular 
cartilage explants [23], and to inhibit PG release 
from IL-1, tumour necrosis factor-~ (TNF-~) or 
basic fibroblast growth factor (b-FGF) treated 
bovine articular cartilage explants [24]. However, 
in one case, although PG loss from cartilage was 
blocked, the HA did not block cytokine-mediated 
protein synthesis uppression or matrix metallo- 
proteinase (MMP) induction [22]. Therefore, more 
studies are required to ascertain mechanism(s) of 
action of HA in these culture models. The effect 
of HA in blocking damage in vivo has been studied 
in many different types of models of cartilage 
damage as described in the accompanying 
manuscript, part II. 
We have used a well-characterized cartilage 
damage system to test the effects of a commercial 
preparation of HA and its mode of action. This 
system employs fragments of native fibronectin 
(Fn-f) which we have shown to cause cartilage 
chondrolysis in vitro [25] and in vivo [26]. These 
Fn-fs bind to and penetrate cartilage tissue [27], 
resulting in greatly-enhanced levels of collagen- 
ase, gelatinases and stromelysin-1 (MMP-3) [25], 
as well as suppression of PG synthesis [28]. 
These two activities cause up to 50% degradation 
and loss of the PG from cultured cartilage, 
resulting in essentially irreversible damage [28 
30]. This rate of PG degradation and loss may 
be two to three orders of magnitude faster 
than experienced in arthritic diseases. A major 
MMP involved in this rapid PG degradation is 
MMP-3 [30], and its induction, as well as the 
suppression of PG synthesis, appear to be mediated 
through Fn-f mediated release of TNF-~, IL-I~, 
IL-lfl and IL-6 [31]. The relevance of this model 
to human diseases is supported by the observations 
that elevated levels of Fn-fs are found in the 
synovial fluids of patients with OA and rheumatoid 
arthritis [32], and that injection of Fn-fs into 
rabbit knee joints causes over 50% removal of 
knee joint articular cartilage PG within 7 days 
[261. 
Since this Fn-f model involves extensive carti- 
lage damage and physical penetration of the 
mediator into cartilage tissue, this model serves as 
an ideal test system for HA, which may establish 
a physical barrier on the superficial surface of 
cartilage. We have investigated the ability of 
800-kDa HA to slow Fn-f mediated cartilage 
chondrolysis and to restore the PG content of Fn-f 
damaged cartilage tissue. The 800-kDa HA form 
was focused on in these studies because of reports 
of greater efficacy of higher mass forms [17 22]. In 
an accompanying manuscript, we report he effects 
of 800-kDa HA on blocking cartilage PG depletion 
in knee joint cartilage of rabbits injected with the 
Fn-f and the reparative properties in this in vivo 
model. 
Materials and Methods 
CHEMICALS AND REAGENTS 
All common chemicals and reagents, as well as 
fetal bovine serum, were from Sigma Chemical Co. 
(St. Louis, MO, U.S.A.). HA of masses of 60, 250 and 
800 kDa and 5-aminofiuoresceinated 800-kDa HA 
were provided by Seikagaku Corporation (Tokyo, 
Japan). The 800-kDa form is denoted HA/800 here. 
NHS-biotin and FITC-avidin were from Pierce 
Chemical Co. (Rockford, IL, U.S.A.). Protein G-125I 
(10 pCi/mg) Inc and 35S-sulfate (43 Ci/mg S) were 
from ICN Biomedicals Inc. (Cosa Mesa, CA, 
U.S.A.). Enhance solution was from New England 
Nuclear (Boston, MA, U.S.A.). 
ISOLATION OF FN-FS 
Fn-fs were generated from human Fn as 
described [29, 33]. The Fn-f tested was a well- 
characterized amino-terminal 29-kDa Fn-f, which 
has been found to be the most potent and is 
referred to as the Fn-f [25]. 
EXPLANT CARTILAGE CULTURES 
Culturing of slices of bovine articular cartilage 
was performed as described [25, 27-30] in Dul- 
becco's modified Eagle's medium (DMEM) contain- 
ing 50U/ml penicillin-streptomycin, with or 
without 10% fetal bovine serum, and with 50-80 mg 
cartilage per 2 ml/well. The native fibronectin was 
not removed from the serum because we have 
shown that it does not interfere with Fn-f mediated 
cartilage chondrolysis [25]. Three culture wells 
were treated identically in order to determine ach 
mean and standard deviation value (S.D.). Each 
experiment was performed three times with bovine 
cartilage collected on 3 different days but cultured 
and tested identically. The data shown are the 
averages from a typical culture experiment. In 
testing of HA, the HA was added 24h before 
addition of the Fn-f. 
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PG-RELEASE FROM ORGAN CULTURES EXPOSED TO 
THE FN-F 
Release of PG into the culture media was used as 
one index of cartilage damage. Kinetic constants 
for rates of PG release into the conditioned media 
were measured as described [25, 28] by assays of PG 
content of the conditioned media using the 
dimethylmethylene blue (DMB) dye-binding assay 
as described [25, 28]. Each experimental mean and 
S.D. were based on assays of three culture wells. 
PG-CONTENT OF CARTILAGE 
Decreases in PG content of articular cartilage 
during culture as mediated by Fn-f was used as a 
second index of cartilage damage and were 
measured as described [29] using the DMB assay on 
papain digests of cartilage. Each experimental 
mean and S.D. were based on assays of three 
culture wells. Error bars on figures correspond to 
S.D. values. 
CHARACTERIZATION OF INTERACTION OF 
5-AMINOFLUORESCEINATED HA/800 WITH CARTILAGE 
Cartilage was incubated with l mg/ml 5- 
aminofluoresceinated HA/800 (provided by Seika- 
gaku Corporation, Tokyo, Japan) for 3 days in 10% 
serum/DMEM. The media were then changed to 
remove exogenous HA. Slices were removed at 
various times, extensively washed with DMEM 
and subjected to fluorescence microscopy as 
described above. Photography was performed 
using 1.5 min exposures. 
WESTERN BLOT ANALYSIS OF MMP-3 
A protein solution, typically obtained from 
conditioned media derived from 3-25 mg cartilage, 
was dialyzed and concentrated to 201tl and 
subjected to electrophoresis by the method of 
Laemmli [35]. Western blotting with MMP-3 
anti-sera nd autoradiography were performed as 
described [30]. 
HISTOCHEMICAL CHARACTERIZATION OF CARTILAGE 
TISSUE 
Cartilage samples were fixed for 1 week in 10% 
neutral buffered formalin containing 5% cetylpyri- 
dinium chloride, dehydrated in ascending rades of 
ethanol and then embedded in paraffin. Micro- 
scopic sections (8 pro) of the samples were stained 
with hematoxylin and eosin and with toluidine 
blue [34] to demonstrate matrix PG. 
MICROSCOPIC CHARACTERIZATION OF INTERACTION 
OF BIOTINYLATED FN-F WITH CARTILAGE 
Solutions (2 ml) of 0.5 mg/ml Fn-f in 0.1 M sodium 
bicarbonate, pH 8.5, were reacted with NHS-biotin 
as described by Pierce Chemical Co. Cartilage was 
incubated with 1 mg/ml HA/800 in 10% serum/ 
DMEM with or without 100 nM biotinylated Fn-f. 
After 2 days, cartilage was recovered, subjected to 
cryosectioning (10pro) and slides exposed to 
1 mg/ml avidin-rhodamine in 0.1 mg/ml bovine 
serum albumen in PBS. After 1 h, slides were 
incubated with PBS-albumin for 1 h and then 
washed with a slow stream of PBS-albumin (3 ml 
per section). Sections were then rinsed for 5 min in 
PBS and mounted in glycerol on cover slides. 
Slides were then visualized with an Olympus BH-2 
microscope quipped with epifluorescence using 
appropriate filters for fluorescein. A ×10 objective 
and ×2 ocular were used to photograph, using 400 
ASA Kodak Tri-X film pushed to 1600 ASA with 
4 min per exposure. 
RATES OF 3~S-SODIUM SULFATE INCORPORATION 
35S-sulfate incorporation was used as an index of 
synthesis of sulfated PG. Rates were measured as 
described [28, 29] with six similar culture wells 
used to calculate means and S.D. values. 
RESTORATION OF PG IN FN-F TREATED CARTILAGE 
Cartilage tissue was cultured in 10 or 20% 
serum-DMEM and the Fn-f added to a 100 nM final 
concentration. Media were changed every other 
day. At 7 days, samples of cartilage were removed, 
cartilage digested with papain and total PG in the 
digest determined with the DMB assay to confirm 
that the PG content had decreased by about 50%. 
The media in some of the cultures containing 
100 nm Fn-f were replaced with media containing 
only 10 or 20% serum-DMEM and 1 mg/ml HA/800. 
Media were changed every other day and PG 
assays of cartilage, after papain digestion per- 
formed at days 14, 21 and 28. Each experimental 
mean and S.D. were based on assays of at least 
three culture wells. Error bars on figures corre- 
spond to S.D. values. 
Resu l ts  
EFFECT OF HA/800 ON FN-F MEDIATED PG RELEASE 
HA/800 did not decrease the rate of Fn-f 
mediated PG release into the culture media in 
serum free, conditions. Cartilage was cultured in 
serum-free insulin-like growth factor-1 (IGF-1) 
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supplemented condit ions (25 ng/ml) to test the 
abil ity of a cont inuous or 1 day pretreatment with 
HA/800 to block Fn-f mediated PG release into the 
media. A concentrat ion of 0.1 or 1 mg/ml HA/800 
did not signif icantly decrease the rates of PG 
release due to 100, 300 or 1000 nM Fn-f (data not 
shown). 
EFFECT OF HA/800 IN LONG-TERM CULTURES 
HA/800 suppressed Fn-f mediated carti lage PG 
depletion in long-term 21 day cultures in 10% 
serum-DMEM. We next tested the effect of HA/800 
in 10% serum where the rates of PG depletion are 
decreased several fold as compared with serum-free 
conditions [25, 28, 30]. This also allowed us to 
monitor  the PG depletion over a longer period, of 
up to 21 days. Fig. 1 shows that  a continuous 
incubation with either 0.1 or 1 mg/ml HA/800 
protected against Fn-f mediated PG depletion 
maximal ly from days 0 to 7 with half  the protection 
lost by about 12 days. By 14 days, most of the 
protect ion had been lost. 
A single 1 day pretreatment  of cart i lage with 
HA/800 was effective in blocking Fn-f mediated 
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Fro. 1. Test of effect of continuous incubation with 0.1 
and 1 mg/ml HA/800 on blocking PG depletion by 100 nM 
Fn-f in long-term 21 day cultures in 10% serum-DMEM- 
bovine articular cartilage slices (about 60 mg/well) were 
removed from bovine joints and added to 2 ml culture 
wells in 10% serum/DMEM. After a 2 day equilibration, 
the cultures were adjusted to 0.1 or 1 mg/ml HA/800. 
After another 24h, the media were removed and 
replaced with media containing HA/800 and with or 
without 100 nM Fn-f. Every other day media was changed 
to allow a continuous incubation with HA/800 and Fn-f. 
At days 7, 14, 21 cartilage was removed, subjected to 
papain digestion and total PG measured using the DMB 
assay. Curves correspond to control with nothing added 
(O); 100 nM Fn-f added at day 0 and included each day 
in culture (0); addition of HA/800 at day 0, followed by 
addition of Fn-f after 1 day and continuous culture in 
presence of both Fn-f and 0.1 mg/ml HA/800 (V) or Fn-f 
and 1 mg/ml HA/800 (V). 
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FIG. 2. Test of effect of a single 1 day pretreatment with 
0.1 and 1 mg/ml HA/800 on blocking PG depletion by 
100 nM and 10 nM Fn-f in long-term 21 day cultures in 
10% serum-DMEM. (a) Effect of 0.1 mg/ml HA/800 on 
100 nM Fn-f. Curves shown are control (O), 100 nM Fn-f 
added at day 0 (0), 1.0 mg/ml HA added from day 0 
through day 1 and the Fn-f added at day 1 through day 
28 (V). (b) Effect of 1 mg/ml HA/800 on 100 nM Fn-f 
activity. Curves are identical to (a), except 1 mg/ml 
HA/800 was tested. (c) Effect of a single 1 day 
pretreatment with 1 mg/ml HA/800 on blocking PG 
depletion by 10 n~ Fn-f. Conditions were as in (a): except 
10 nM Fn-f was used. 
cart i lage PG depletion in long-term 21 day cultures 
in 10% serum-DMEM. We next tested whether a 1 
day pretreatment  of cart i lage with HA/800 was as 
effective as continuous treatment over a 21 day 
period. We first tested the abil ity of a pretreatment 
with HA/800 to block action of 100nM Fn-f. 
Fig. 2(a) shows effects similar to those of the 
continuous incubations in Fig. 1, except in the 
pretreatment  conditions with 0.1 mg/ml HA/800, 
half  of the protect ion was lost by 7 days instead of 
by 12 days as shown for continuous treatment. 
However, pretreatment  with 1 mg/ml HA/800 for 1 
day was as effective as a continuous incubation 
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and suppressed PG depletion for 7 days. The 
amount of 4~rotection can be estimated based on 
our observation that 10 nM Fn-f does not cause PG 
depletion until 7 days (29; and below), which 
suggests that HA/800 has reduced the effectiveness 
of 100 nM Fn-f to that of 10 nM Fn-f and caused a 
90% blocking effect. 
The effect of a single 1 day pretreatment with 
1 mg/ml HA/800 on blocking PG depletion by a 
lower concentration of the Fn-f, 10 nM, in 21 day 
cultures in 10% serum-DMEM was tested next. 
Fig. 2(c) shows that 10 nM Fn-f did not cause severe 
PG depletion until after day 14 and eventually 
caused 50% PG depletion by day 21. However, a 
single 1 day pretreatment with HA/800 afforded 
complete protection. 
EFFECT OF SMALLER HA FORMS 
HA of 60-kDa was ineffective in blocking Fn-f 
mediated PG depletion while 250-kDa was as 
effective as 800-kDa. Smaller HA forms were tested 
for comparison. Cartilage cultures were adjusted 
to i mg/ml 60 or 250-kDa HA and after 24 h, the 
media were adjusted to 0.1 #M Fn-f. Fig. 3 shows 
that after 5 days, the 60-kDa HA did not decrease 
Fn-f mediated PG depletion while the 250-kDa HA 
was as effective as HA/800 and blocked PG 
30 
20 \ ,  - . . . . . . . .  " ............. ~.~f f~ 
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FIG. 3. Comparison of the effect of continuous incubation 
with 1 mg/m160-kDa, 250-kDa or HA/800 on blocking PG 
depletion by 100 n~ Fn-f in long-term 21 day cultures in 
10% serum-DMEM. Cultures were established asin Fig. 
1 and adjusted to 1 mg/ml of three different mass forms 
of HA. After another 24 h, the media was removed and 
replaced with media containing HA and with or without 
100 nM Fn-f. Every other day media was changed to allow 
a continuous incubation with HA and Fn-£ At days 7, 14, 
21 cartilage was removed and PG measured. Curves 
correspond to control with nothing added (O); 100 nM 
Fn-f added at day 0 and included each day in culture (Q); 
addition of 1 mg/ml 60-kDa HA (y), 250-kDa HA (V) or 
HA/800 (O). Culturing was continued in the presence of 
both Fn-f and HA. 
depletion for 14 days in culture. Thus, the 
protective ffect of HA required a mass greater 
than 60-kDa. The HA/800 form remained the focus 
of subsequent s udies. 
MICROSCOPIC  CHARACTERIZAT ION 
Microscopic haracterization f cartilage slices 
confirmed that HA/800 suppressed Fn-f mediated 
PG depletion. Staining with toluidine blue of PG 
in control, Fn-f treated and HA protected tissue 
at day 6 in culture confirmed the results of PG 
assays and showed that HA/800 had a protective 
effect. Control sections (Fig. 4(a)] showed stain 
concentrated around the cells in the pericellular 
region and evenly distributed in the inter-territo- 
rial region between the cells. The superficial zone 
of cartilage, including the articular surface 
stained less well than the deeper regions of 
cartilage. However, sections from Fn-f treated 
cartilage [Fig. 4(b)] showed a diminished staining 
pattern. This pattern was first evident at day 2 in 
culture (data not shown). Visual examination 
suggested that cell numbers were unaffected by the 
Fn-f treatment. The articular surface appeared to 
be unaffected by Fn-f treatment. Sections from 
HA/800 protected cartilage [Fig. 4(c)] demon- 
strated normal PG staining and were virtually 
indistinguishable from control sections. 
EFFECT OF VISCOSITY ON FN-F ACTIVITY 
Dextran, which increased the viscosity of the 
culture media, did not suppress, the activity of the 
Fn-f. In order to test whether the viscosity 
increasing effect of HA/800 might explain the 
protective ffect, dextran of 2 MDa was included in 
culture media at concentrations of 0.1, 1, 5 or 
10 mg/ml in the presence of 0.1 gM Fn-f to increase 
the viscosity of the media. After 5 days of culture, 
the control tissue showed 34.9__ 3.1#g PG/mg 
cartilage, the Fn-f treated tissue showed 20.5 ± 2.3 
and tissue co-treated with Fn-f and dextran at 0.1, 
1, 5 or 10 mg/ml dextran showed PG contents of 
19.3 ± 2.5, 18.9 + 1.9, 17.7 ± 2.4 and 19.9 ± 3.4 pg/ 
mg cartilage, respectively. Therefore, increasing 
the viscosity of the culture media was not 
sufficient for blocking the action of the Fn-f. 
HA/800-SUPPRESSED PENETRATION OF 
BIOTINYLATED FN-F INTO CARTILAGE TISSUE 
We attempted to visualize microscopically the 
penetration of biotinylated Fn-f into tissue in 
the presence or absence of HA/800. Fig. 5 shows 
that incubation of cartilage with HA/800 markedly 
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(b) 
I~  ~, 
B INDING OF  HA/800 
HA/800 bound mostly to the superficial surface. 
Fig. 6(a) shows that when fluoresceinated HA/800 
was added to cartilage for 3 days, it bound in a 
thick layer on the superficial surface with only 
very faint signal throughout he tissue. This 
surface binding may account for the physical 
blocking of penetration of the Fn-f. To test how 
long the HA/800 remained bound, the exogenous 
labeled HA was removed from the media, the 
culture media changed twice during the next 7 
days and after an additional 7 days, the tissue 
analyzed. As shown in Fig. 6(b), the fluorescence 
was of similar intensity as at 3 days, indicating 
that HA/800 still remained tightly bound to the 
articular surface. Note that when compared with 
the superficial surface, much less HA/800 bound to 
the lower cut surface near the calcified region, 
which was also freely accessible during the 
culture. 
LACK OF INTERACTION OF HA/800 AND Fn-f IN DMEM 
HA/800 and the Fn-f did not interact in DMEM. 
In order to test whether HA/800 blocked tissue 
penetration of the Fn-f by interacting with it and 
forming a high molecular weight, non-penetrating 
FIG. 4. Microscopic haracterization a d toluidine blue 
staining of HA/800 protected tissue (a) shows control 
tissue: (b) shows tissue incubated with 100 nM Fn-f; and 
(c) shows tissue incubated with 100 nM Fn-f and 1 mg/ml 
HA/800. All tissue was analyzed after 6 days of culture by 
toluidene blue staining to visualize PG. Arrows indicate 
the articular cartilage. Original magnification s x10. 
(a) 
29-kD 
(b) 
decreased the p netration ofbiotinylated Fn-f into 
cartilage. Note that the control [Fig. 5(a)] with Fn-f 
added without HA/800, showed high levels of Fn-f 
on the articular surface and a high background 
throughout the entire full-thickness ection, as 
well as intense localization around cell clusters. 
However, addition of HA/800 with the Fn-f 
[Fig. 5(b)] decreased the amount of label through- 
out, with the greatest effect on the labelling of the 
superficial surface. 
ARTZ 
+ 29-kD 
FIG. 5. Effect of HA/800 on blocking penetration of
biotinylated Fn-f into cartilage as assessed by fluor- 
escence. Cartilage was incubated with 1 mg/mI HA/800 
in 10% serum/DMEM with (a) or without (b) 100r~f 
biotinylated Fn-f for 2 days as described in Methods, and 
sections visualized by fluorescence microscopy. 
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(a) 
(b) 
with reduced release of MMP-3 and lesser 
suppression of PG synthesis. If the amount of Fn-f 
penetrating into the tissue had been reduced by 
HA/800, there should have been a reduction in the 
magnitude of two catabolic activities of the Fn-f, 
enhanced release of MMP-3 and suppression of PG 
synthesis. Fig. 7 shows by Western blot analysis of 
conditioned media, that use of both 0.1 or I mg/ml 
HA/800 led to a lower induction of MMP-3. The 
amount of M1VtP-3 in 0.1 or I mg/ml HA/800 treated 
culture media at day 7 in culture was only 35 and 
21%, respectively, of that in cultures treated with 
Fn-f only, based on densitometric analysis of the 
bands. Therefore, the indirect effect of lmg/ml 
HA/800 was to suppress MMP-3 release fivefold. 
The size of the MMP-3 bands was 43-kDa which 
corresponds to active MMP-3 and not pro-MMP-3 
of 55-kDa. Therefore, the release of (pro)MMP-3 
was suppressed but not the activation of pro-MMP- 
3 to MMP-3. Table I shows that while 100 nm Fn-f 
suppressed PG synthesis by about 50% as also 
reported elsewhere, the presence of l mg/ml 
HA/800 caused a reversal of the suppression while 
0.1mg/ml HA/800 did not have a significant 
effect. 
FIG. 6. Visualization of interaction of 5-aminofluores- 
ceinated 800-kDa HA with cartilage tissue. Bovine 
articular cartilage tissue in 10% serum-DMEM was 
cultured in the presence of 1 mg/ml fluorescein labeled 
HA/800 (provided by Seikagaku Corporation) for 3 days. 
The media was then removed and 10% serum-DMEM 
added back. Cartilage was removed after 3 and 10 days 
of culture and subjected to cryo-sectioning as described 
in Fig. 5 and fluorescence microscopy as described in 
Methods. 
complex, the components were mixed in DMEM 
and 24h later, the mixture subjected to gel 
filtration on Sephacryl S-300 eluted with 100 mM 
sodium phosphate, 150 mM NaC1, pH 7.4. The yield 
and elution positions were compared with that of 
the same quantity of Fn-f alone. The Fn-f mixed 
with HA/800 eluted at the position expected for 
non-complexed Fn-f and the area of the peak was 
similar to that observed with Fn-f alone (data not 
shown). Therefore, interaction of HA/800 with Fn-f 
had not occurred under these conditions. 
EFFECT ON MMP-3 AND PG SYNTHESIS 
The effect of HA/800 on suppression of Fn-f 
mediated cartilage PG depletion was associated 
68 ,:'~.4~ 
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FIG. 7. Effect of HA/800 on blocking Fn-f mediated 
enhanced release of MMP-3--conditioned media from 
cultures prepared as in Fig. 1 were reduced and 
subjected to electrophoresis on 10% Laemmli SDS gels 
as described [30]. The gels were blotted and the blots 
reacted with rabbit anti-human pro-MMP-3 anti-sera 
and 12SI-labeled protein G for autoradiography as
described [30]. Shown are size standards in lane S; 2 pg 
of human pro-MMP-3 in lane 1, media from Fn-f treated 
cultures in lane 2; media from Fn-f and I mg/ml HA/800 
treated cultures in lane 3; media from Fn-f and 0.1 mg/ml 
HA/800 treated cultures in lane 4. 
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Table I 
Effect of HAl800 on blocking Fn-f mediated PG synthesis suppression 
% of control sulfate incorporationt 
Condition* mean ± S.D. (P value) 
Control 100 + 16 
100 nM Fn-f 53 ± 8 
0.1 mg/ml HA 109 i 9 
1.0 mg/ml HA 109 ± 8 
100 nM Fn-f+ 0.1 mg/ml HA 55 ± 5(ns):~ 
100 nM Fn-f+ 1.0 mg/ml HA 92 ± 7(s)$ 
*Cartilage in 10% serum/DMEM was incubated with 0.1 mg/ml HA/800 or with 100 nM Fn-f or 
with 0.1 mg/ml HA/800 and Fn-f for 24 h followed by adjustment of cuP, ures to 10 pCi/m135S sodium 
sulfate. Labeling was allowed to continue for 2 h, followed by washing ofthe cartilage and extraction 
of cartilage with 4 M GuHC1, 20 mM EDTA, 0.1 M sodium acetate, pH 5.0. The extracts were 
exhaustively dialyzed and subjected toscintillation counting. 
tThe value shown are percent of incorporation for control cartilage and values of standard deviation 
(S.D.). P values were based on Student's t-test where avalue of less than 0.05 was considered significant. 
Number of samples was 6. 
:~ns (not significant); s (significant). Based on comparison with 100 nM Fn-f data. 
HA/800 PROMOTED PART IAL  RESTORATION OF PG IN  
FN-F TREATED CART ILAGE 
Because HA/800 blocked Fn-f mediated PG 
depletion, we considered that it had potential for 
repairing Fn-f damaged cartilage. Cartilage was 
first damaged by treatment with Fn-f in 10 or 20% 
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FIG. 8. Test of ability of lmg/ml HA/800 to promote 
restoration of lost PG in 10 (a) and 20% serum-DMEM 
(b). Cartilage was adjusted to 10% serum (a) or 20% 
serum (b)--DMEM (Control; O), or to 100 nM Fn-f for 
days 0 to 7 only (O), or to 100 nM Fn-f for days (L7, 
followed by adjustment to 1 mg/ml HA/800 for days 7 21 
without Fn-f (V). 
serum-DMEM and then treated with 1 mg/ml 
HA/800 without Fn-f. Conditions of 20% serum, 
which would contain higher concentrations of 
anabolic factors, were tested to determine if repair 
could be optimized. Fig. 8 shows that repair did not 
occur in the presence of 10 (a) or 20% (b) serum 
alone. Linear regression analysis howed that the 
slopes for these control curves from days 7-21, in 
10% serum (a) or in 20% serum (b), were not 
significantly greater than zero. However, HA/800 
increased the respective slope from 0 to 
0.174 _+ 0.0248 (r2=0.96) in 10% serum [Fig. 8(a)]; 
this slope was significantly greater than zero 
(P= 0.02). Fig. 8(b) shows that there was a lower 
amount of initial PG depletion in 20% serum as 
compared with 10% serum, however HA/800 
increased the slope from 0 to 0.189+_0.041 
(r 2= 0.91), but with a lower degree of significance 
(P= 0.04). We conclude that HA/800 did promote 
significant repair in vitro of Fn-f treated and 
damaged cartilage. 
Discuss ion  
HA/800 did not block Fn-f mediated PG release 
in serum-free conditions, likely because the rate of 
degradation is too great. Serum-free conditions 
allow a decrease in PG content by 90% within 3 
days [25, 27]. Therefore, cultures were established 
in 10% serum, which would contain high concen- 
trations of serum proteinase inhibitors. We have 
shown that addition of serum-derived proteinase 
inhibitors to conditioned media does slow Fn-f 
mediated amage [30] and that conditions of 10% 
serum slows the rate of PG depletion such t at half 
the total PG is lost within 7 days [29]. Under the 
10% serum conditions, continuous incubation with 
either 0.1 or 1 mg/ml HA/800 slowed the half-time 
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for 100 nM Fn-f mediated PG depletion from 3 to 15 
days. Based on the half-time for PG depletion, 
HA/800 decreased the effectiveness of 100 nM to 
that of 10 nM Fn-f, a quite significant effect. 
Histologic analysis of HA/800 protected tissue 
confirmed that PG depletion was blocked. 
A single pre-treatment with 1 mg/ml HA/800 for 
1 day, followed by its removal, was as effective as 
a continuous incubation in blocking 100 nM Fn-f, 
although in the case of 0.1mg/ml HA/800, 
continuous treatment was necessary for maximal 
blocking activity. Further, as we decreased the test 
concentration of Fn-f from 100 to 10 nM Fn-f and 
again tested a single treatment with 1 mg/ml 
HA/800, total blocking activity was observed over 
a 26 day period. Because the media were changed 
up to 13 times during the tests of pretreatment, 
these data are consistent with the observation 
that fluoresceinated HA/800, when added to media 
at 1 mg/ml, did not perceptively dissociate from 
cartilage when it was used to briefly pre-treat 
cartilage. 
HA forms of 60-kDa were ineffective in blocking 
PG depletion, while a 250-kDa form was as 
effective as HA/800, suggesting that the protective 
effect required a minimal molecular weight. The 
blocking action of HA/800 did not occur simply by 
enhancing the viscosity of the culture media and 
thus, slowing diffusion of the Fn-f into cartilage. 
This was shown by the inability of dextran to block 
PG depletion. The protective ffect of HA/800 was 
not likely due to it complexing tightly with the Fn-f 
because a complex could not be visualized after 
mixing the components in DMEM and subjecting 
the mixtures to gel filtration in 100 mM sodium 
phosphate, 150 mM NaC1, pH 7.4. However, it is 
possible that interaction might occur in the 
presence of 10% serum/DMEM as used in the 
cultures. 
The most likely explanation for the mechanism 
of action of HA/800 is that it blocked penetration 
of the Fn-f into tissue. Microscopy of cartilage 
cultured with labeled Fn-f showed that HA/800 
greatly decreased Fn-f binding on the superficial 
surface, diffusion throughout he matrix and the 
intense localization around cell clusters. Parallel 
studies with fluorescently labeled HA/800 showed 
that HA/800 bound to the superficial surface 
without penetrating deeply. Because the N-termi- 
nal 29-kDa Fn-f used here can bind heparinoid 
compounds [36], the HA/800 may have bound PG 
near the surface and decreased binding and 
subsequent penetration of the Fn-f. Others have 
proposed that HA may act by slowing penetration 
of macromolecules byenhancing viscosity near the 
articular surface [37], although our tests using 
dextran showed that altering the viscosity of the 
bulk media did not block the action of the Fn-f. 
Whatever the mechanism for HA-800 binding to the 
surface, it should be noted that our data showed 
that HA/800 bound mostly to the superficial 
surface of cultured cartilage, although the basal 
cut surface was also accessible, and the binding 
appeared to be of high affinity because HA/800 was 
still present after several changes of culture media. 
Because it was conceivable that HA/800 may 
have decreased cartilage PG depletion simply by 
blocking effusion of degraded PG out of the 
cartilage, we investigated whether HA blocked 
two of the major causative vents involved in Fn-f 
mediated PG depletion, enhanced expression of 
MMP-3 and suppression of PG synthesis. The data 
indicated that 1 mg/ml HA greatly decreased both 
activities, while 0.1 mg/ml HA was ineffective or 
much less effective, consistent with measurements 
of PG loss. It should be noted that others have 
reported that HA of about 250-kDa suppresses PG 
synthesis while HA of much higher mass did not 
[38]. While we did not test HA/250 for PG synthesis 
suppression, it was as effective as HA/800 in terms 
of blocking PG depletion. If it does suppress PG 
synthesis, this may suggest hat this effect did not 
contribute to a decrease in steady state levels of 
PG as measured here during the time course of the 
culture. Nonetheless, HA/800 did block the effect 
of the Fn-f but by itself had no effect on PG 
synthesis in the absence of the Fn-f. 
Because HA has been suggested to repair 
cartilage in patients with OA ]9-11] and in various 
animal models of cartilage damage, as discussed in 
the accompanying manuscript, this activity was 
tested in vitro and found to be significant. This 
activity could not result from the ability of HA/800 
to block penetration of the Fn-f into the cartilage 
because the Fn-f had already been removed from 
the culture. It is conceivable that HA/800 bound to 
catabolic mediators released into the media, 
thereby blocking their re-entry into the tissue and 
effectively decreasing their concentrations. How- 
ever, a more likely explanation might be that HA 
acted as an anti-oxidant because it is known to 
inactivate reactive oxygen species [20], and 
reactive oxygen species are known to be released 
from chondrocytes in the presence of IL-1 and 
TNF-~ and to mediate cytokine activities [39, 40]. 
This explanation is plausible because we have 
shown that the Fn-f operate through catabolic 
cytokines [31], that the action of the cytokines can 
be blocked with anti-oxidants [41] and that 
anti-oxidants promote restoration of PG in Fn-f 
treated tissue [42]. If cytokine action is prolonged 
after the Fn-f is removed from damaged cartilage, 
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[which we have shown to be the case (Homandberg 
et al., unpublished observations)], the HA, as an 
anti-oxidant, may block prolonged cytokine action 
long enough to allow restoration of PG. 
In summary, HA/800 slowed the Fn-f mediated 
carti lage chondrolysis by binding to the superficial 
surface of carti lage slices and greatly decreasing 
penetrat ion of Fn-f into carti lage tissue and the 
resultant catabolic activities of the Fn-f, enhanced 
release of MMP-3 and suppression of PG synthesis. 
HA/800 also enhanced restoration of PG in Fn-f 
damaged cartilage, perhaps through its anti-oxi- 
dant activity. The relevance of the work presented 
here is strengthened by our work in a companion 
manuscript in which we report that HA/800 also 
decreased knee carti lage PG depletion when 
injected with Fn-f into rabbit knee joints and also 
exhibited reparative properties. 
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